Answer
Yes, for licensed invasive fungal infections, but age eligibility differs between oral and intravenous formulations. Specialist paediatric oversight is required.
Sources for this answer
- CRESEMBA 200mg Powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- Cresemba 100mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.